Wordt geladen...
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition
Despite recent advances in the treatment of chronic lymphocytic leukemia (CLL) with chemoimmunotherapy, many CLL patients are older or frail and cannot tolerate aggressive chemotherapy. Even those who can inevitably develop resistance due to factors such as deletion of pro-apoptotic factors like TP5...
Bewaard in:
| Gepubliceerd in: | Leuk Lymphoma |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557771/ https://ncbi.nlm.nih.gov/pubmed/23614795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.796051 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|